DIN 02529459 — AMIKACIN SULFATE INJECTION 250 MG
AMIKACIN SULFATE INJECTION is a solution of Amikacin marketed by JAMP PHARMA CORPORATION. The full Amikacin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02529459
- Brand name
- AMIKACIN SULFATE INJECTION
- Active ingredient
- Amikacin
- Strength
- 250 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Manufacturer
- JAMP PHARMA CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Aminoglycoside antibiotic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Amikacin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02486717 | AMIKACIN SULFATE INJECTION | 250 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED |
| 02242971 | AMIKACIN SULFATE INJECTION USP | 250 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED |
| 02481073 | AMIKACIN SULFATE INJECTION USP | 500 MG | SOLUTION | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02506599 | VPI-AMIKACIN | 500 MG | SOLUTION | VPI PHARMACEUTICALS INC | DORMANT |